Inhibrx Biosciences Inc. Stock Analysis & AI Score
Inhibrx Biosciences Inc. (INBX) has an ST Score of 55.5 (B-), driven by its Valuation (A+) and held back by its Growth (D-). Analysts rate it Buy with a $285.00 price target (+183.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Inhibrx Biosciences Inc. (INBX) has an ST Score of 55.5 (B-), driven by its Valuation (A+) and held back by its Growth (D-). Analysts rate it Buy with a $285.00 price target (+183.9% upside).
- Strongest
- ValuationA+
- Weakest
- GrowthD-
All factor grades
- ValuationA+
- ForecastA
- MomentumB+
- Financial StrengthB-
- ProfitabilityC-
- GrowthD-
- Piotroski3/9
Contact
INBX stock: frequently asked questions
What is INBX's ST Score?
Inhibrx Biosciences Inc. (INBX) has an ST Score of 55.5 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is INBX a buy, hold, or sell?
Analysts rate INBX a Buy, with a price target of $285.00 (+183.9% vs the current price). Our ST Score grades it B- (55.5/100). The ST Score is a data-driven signal, not a recommendation.
What are INBX's factor grades?
Valuation A+, Profitability C-, Financial Strength B-, Momentum B+, Growth D-, Forecast A.
What is INBX's valuation grade?
Inhibrx Biosciences Inc. (INBX) earns a valuation grade of A+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is INBX's growth grade?
Inhibrx Biosciences Inc. (INBX) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is INBX's profitability grade?
Inhibrx Biosciences Inc. (INBX) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is INBX's financial strength grade?
Inhibrx Biosciences Inc. (INBX) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for INBX?
The average analyst price target for Inhibrx Biosciences Inc. (INBX) is $285.00 from 5 analysts, which is +183.9% versus the recent price of $100.40.
What is INBX's Piotroski score?
Inhibrx Biosciences Inc. (INBX) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.